FINANCING AND ADDITIONAL SERVICES AMENDMENT
Exhibit 1.3
 |
Primary Capital LLC Member FINRA, SIPC 000 Xxxxxxxx Xxx, 0xx Xxxxx Xxxxx, XX 00000 Investment Banking, Financial Services |
FINANCING AND ADDITIONAL SERVICES AMENDMENT
October 12, 2021
Xxxx Xxxxxxxx, CFO
RespireRx Pharmaceuticals Inc.
000 Xxxxxx Xxxx, Xxxxx X
Glen Rock, New Jersey 07452
Dear Xx. Xxxxxxxx:
Reference is made to the Financing and Additional Services Agreement between Primary Capital, LLC (“PC”) and RespireRx Pharmaceuticals, Inc. (the “Company”) dated August 6, 2021, as amended on September 29, 2021 (collectively, the “Agreement”). The undersigned parties hereby agree that the Agreement by and between PC and the Company shall be amended as follows:
| ● | The expenses which are incurred by PC or any co-agents in connection with services rendered by such parties to the Company in connection with this offering, and for which the Company shall be responsible shall not exceed $35,000 in the aggregate in the event of a closing of the offering. This $35,000 amount shall be inclusive of the $25,000 paid by the Company to PC for its legal expenses. |
Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Agreement.
If the foregoing correctly sets forth the understanding between PC and the Company, please so indicate your agreement by signing in the place provided below, at which time this amendment shall become a binding contract.
Sincerely,
Primary Capital LLC,
Securities offered thru VCS Venture Securities LLC
| By: | /s/ Xxxxxx Xxxxx | Date: 10/12/21 | |
| Xxxxxx Xxxxx, Senior Managing Director | |||
| Investment Banking | |||
Accepted and Agreed:
| By: | s/ Xxxx Xxxxxxxx | Date: 10/12/21 | |
| Xxxx Xxxxxxxx, CFO | |||
| RespireRx Pharmaceuticals Inc. | |||
